[Preliminary assessment of felbamate effect on the cerebral bioelectrical activity in children with refractory...

Area of Science:

• Neurology
• Clinical Neurophysiology

Background:

• Refractory epilepsy in children presents significant treatment challenges.
• Lennox-Gastaut syndrome and partial epilepsy are common forms requiring effective interventions.

Purpose of the Study:

• To investigate the influence of Felbamate on cerebral bioelectric activity (EEG) in children with refractory epilepsy.
• To assess Felbamate's impact on EEG abnormalities, discharge duration, and background activity.
• To correlate EEG changes with clinical outcomes in pediatric epilepsy patients.

Main Methods:

• Visual analysis of waking and sleep electroencephalograms (EEG) in 31 children with refractory epilepsy.
• Evaluation of EEG parameters including abnormalities, discharge duration, dominant frequency, and background activity.
• Assessment of Felbamate's effects on sleep spindles and beta activity.

Main Results:

• EEG improvement was observed in approximately 70% of children with Lennox-Gastaut syndrome and 30% with partial epilepsy.
• A positive correlation was found between EEG improvements and clinical outcomes.
• Statistically significant improvement in background EEG activity was noted in both epilepsy groups.
• No significant influence of Felbamate on sleep spindles or increased beta activity was observed.

Conclusions:

• Felbamate demonstrates efficacy in improving EEG findings in children with refractory epilepsy, especially Lennox-Gastaut syndrome.
• EEG improvements correlate with clinical benefits, supporting Felbamate's therapeutic role.
• Felbamate positively impacts background EEG activity without adversely affecting sleep spindles or increasing beta activity.